http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1741431-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae0adfeb8930dcef5c2ca2469e3e5879
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
filingDate 2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5602fc5768e8d06eb045e77728dcd72a
publicationDate 2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1741431-B1
titleOfInvention The combination for treating hyperlipemia
abstract A combination for treating hyperlipemia, which contains the first active component acipimox, and the second active component atorvastatin ,it's pharmaceutical salt, ester, or solvate. Weight ratio of the first and the second active component is (10-80): 1. The combination includes the form of tablet, capsule, granule or pill. The combination of acipimox and atorvastatin shows distinct synergism in reducing serum cholesterol, TG, LDL. Compare to the combination of acipimox and pravastatin or the combination of acipimox and lorvastatin, the combination of acipimox and atorvastatin is better at decreasing lipoprotein and increasing HDL.
priorityDate 2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003162827-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129317935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127754342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127744388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91525289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11865464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128704946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248698204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55303094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5310993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128898221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9851656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226547528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229045510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12040205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87076368

Total number of triples: 82.